I Was Concerned About Biogen Until I Heard These 11 Words From Its CEO

Biogen, facing declines in sales of older drugs, has a lot riding on its newly approved Alzheimer’s disease treatment.
The company recently announced moves to cut costs and favor investments in innovation and new product launches.